Table 3.
Characteristics of 32 AECOPD episodes
| Occurrence of AECOPD after enrolment in PRP, days | 12.8 (10.1–15.6)a |
|---|---|
| Duration of medical intervention, days | 8.2 (6.8–9.5)a |
| Positivity of sputum sample | 9 (28.1)b |
| Courses of corticosteroids | 25 (78.1) |
| Courses of antibiotics | 26 (81.3) |
| Severity of AECOPDc | |
| Mild | 10 (31.3) |
| Moderate | 16 (50.0) |
| Severe | 6 (18.7) |
Notes: Data are presented as mean (CI), mean ± SD, or n (%).
a
Nonnormal distribution.
b
Haemophilus influenzae, n=4; Staphylococcus aureus, n=2; Streptococcus pneumoniae, n=1; Escherichia coli, n=1; Pseudomonas aeruginosa, n=1.
c
See definitions in text.
Abbreviations: AECOPD, acute exacerbation of COPD; PRP, pulmonary rehabilitation program.